📰 Polypid News
Page 2 - Polypid News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Polypid. Real-time updates on events, politics, business and more.
August 8, 2023
PolyPid (NASDAQ:PYPD – Get Free Report) is set to issue its quarterly earnings data before the market opens on Wednesday, August 9th. Parties that wish to listen to the company’s conference call can do so using this link. PolyPid (NASDAQ:PYPD – Get Free Report) last posted its quarterly earnings results on Wednesday, May 10th. The […]
July 5, 2023
PolyPid Ltd. (NASDAQ:PYPD – Free Report) was the recipient of a significant drop in short interest during the month of June. As of June 15th, there was short interest totalling 88,000 shares, a drop of 29.1% from the May 31st total of 124,100 shares. Based on an average daily volume of 112,600 shares, the days-to-cover […]
July 4, 2023
PolyPid Ltd. (NASDAQ:PYPD – Free Report) was the target of a large drop in short interest in June. As of June 15th, there was short interest totalling 88,000 shares, a drop of 29.1% from the May 31st total of 124,100 shares. Based on an average daily volume of 112,600 shares, the days-to-cover ratio is currently […]
June 5, 2023
05.06.2023 - PETACH TIKVA, Israel, June 05, 2023 (GLOBE NEWSWIRE) - PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced it has received an extension of the period to ... Seite 1
May 26, 2023
PolyPid Ltd. (NASDAQ:PYPD – Get Rating) shares traded up 4.8% during trading on Wednesday . The stock traded as high as $0.39 and last traded at $0.37. 94,833 shares were traded during trading, a decline of 67% from the average session volume of 288,958 shares. The stock had previously closed at $0.35. PolyPid Price Performance […]
May 5, 2023
PolyPid Ltd. (NASDAQ:PYPD – Get Rating) was down 1.2% during trading on Tuesday . The company traded as low as $0.40 and last traded at $0.41. Approximately 17,516 shares changed hands during trading, a decline of 95% from the average daily volume of 325,541 shares. The stock had previously closed at $0.41. PolyPid Stock Down […]
February 2, 2023
Raymond James Financial Services Advisors Inc. trimmed its position in shares of PolyPid Ltd. (NASDAQ:PYPD – Get Rating) by 36.5% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 33,814 shares of the company’s stock after selling 19,447 shares during the […]
May 17, 2022
PolyPid (NASDAQ:PYPD – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Tuesday, Zacks.com reports. The firm currently has a $5.25 target price on the stock. Zacks Investment Research‘s price objective suggests a potential upside of 4.79% from […]
April 12, 2022
Wall Street analysts expect that PolyPid Ltd. (NASDAQ:PYPD – Get Rating) will announce earnings of ($0.68) per share for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have issued estimates for PolyPid’s earnings. PolyPid reported earnings of ($0.47) per share during the same quarter last year, which indicates a negative year over […]
March 17, 2022
PolyPid Ltd. (NASDAQ:PYPD – Get Rating) saw a significant increase in short interest in the month of February. As of February 28th, there was short interest totalling 119,900 shares, an increase of 17.1% from the February 13th total of 102,400 shares. Currently, 0.8% of the shares of the stock are sold short. Based on an […]